[COVID-19: Still a place for tocilizumab?][COVID-19: 아직도 토실리주맙이 살 곳인가?]Review Published on 2021-02-012022-09-11 Journal: La Revue de médecine interne [Category] MERS, SARS, 임상, 진단, [키워드] Abstract COVID-19 hyperinflammation interleukin interleukin-6 Interleukine-6 SARS-CoV-2 Still Tocilizumab tocilizumab. [DOI] 10.1016/j.revmed.2020.11.016 PMC 바로가기 [Article Type] Review
Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis중증 코로나19 환자의 인터루킨-6: 후향적 분석Clinical Trial Published on 2020-12-312022-08-13 Journal: PLoS ONE [Category] Biochemistry, MERS, SARS, 임상, [키워드] Admission admitted patients AUROC Blood Blood cells blood concentration C-reactive protein China clinician collected Concentration conducted coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 patient Critically ill critically ill COVID-19 patients cytokine Cytokine storm D-dimers demographic diagnosis of COVID-19 disease evaluate ferritin help highest ICU IL-6 IL-6 level intensive care unit interleukin-6 Interleukine-6 laboratory data Lactate lactate dehydrogenase LDH lymphocyte Lymphocytes Mortality non-survivor outcome parameter pathophysiology Patient patients patients with COVID-19 poor prognosis Predictive Predictive value repeated Result Retrospective analysis Retrospective study risk severity significant difference significantly higher Spread survivor White blood cell White blood cells [DOI] 10.1371/journal.pone.0244628 PMC 바로가기 [Article Type] Clinical Trial